Skip to main content
Figure 5 | BMC Neuroscience

Figure 5

From: Granulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice

Figure 5

Experimental design in the study. Mice with middle cerebral artery occlusion are divided into 4 groups: group#1: mice received G-CSF (30 μg/kg/d, dissolved in 0.3 ml saline, i.p.) for 28 days and BMMC transplantation (1 × 107 cells dissolved in 0.3 ml saline) via tail vein, one time on the first day after middle cerebral artery occlusion; group#2: mice received BMMC transplantation only (1 × 107 cells dissolved in 0.3 ml saline); group#3: mice received G-CSF administration alone (30 μg/kg/d, dissolved in 0.3 ml saline, i.p.) for 28 days; and group#4 received 0.3 ml saline (i.p.) for 28 days.

Back to article page